Skip to main content
SpringerLink
Log in

Immune Monitoring in Cancer Immunotherapy

  • Conference paper
Therapeutic Vaccination Strategies

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 30))

Abstract

The one-century-old idea of turning the immense resources of the immune system against cancer cells as a tool in the treatment of cancer patients has been reinvigorated with the identification of the molecular targets recognized by tumor-specific cytolytic T lymphocytes (CTLs). Indeed, over 40 different antigenic peptides, derived from mostly non-mutated and normally expressed proteins, have been defined that mimic an equal number of CTL-defined tumor antigens. The possibility to chemically synthesize large quantities of well-defined antigenic peptides together with significant progress made in the understanding of in vivo induction of specific CTL responses, have paved the way to new approaches for the design of therapeutic cancer vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allan DSJ, Colonna M, Lamer LL, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM (1999) Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 189: 1149–1155

    Article  PubMed  CAS  Google Scholar 

  • Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94–96

    Article  PubMed  CAS  Google Scholar 

  • Bakker ABH, Burg SH van der, Huijbens RJF, Drijfhout JW, Melief CJM, Adema GJ, Figdor CG (1997) Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type eptitope. Int J Cancer 70: 302–309

    Article  PubMed  CAS  Google Scholar 

  • Bieganowska KD, Höllsberg P, Buckle GJ, Lim DG, Greten TF, Schneck J, Altman JD, Jacobson S, Ledis SL, Hanchard B, Chin J, Morgan O, Roth PA, Hafler DA (1999) Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Taxll-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol 162: 1765–1771

    PubMed  CAS  Google Scholar 

  • Bousso P, Casrouge A, Altman JD, Haury M, Kanellopoulos J, Abastado JP, Kourilsky P (1998) Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity 9: 169–178

    Article  PubMed  CAS  Google Scholar 

  • Braud VM, Allan DSJ, O’Callaghan CA, Söderström K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2 A, B and C. Nature 391: 795–799

    Article  PubMed  CAS  Google Scholar 

  • Busch DH, Pamer EG (1999) T cell affinity maturation by selective expansion during infection. J Exp Med 189: 701–710

    Article  PubMed  CAS  Google Scholar 

  • Busch DH, Pilip IM, Vijh S, Pamer EG (1998) Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8: 353–362

    Article  PubMed  CAS  Google Scholar 

  • Calbo S, Guichard G, Bousso P, Muller S, Kourilsky P, Briand JP, Abastado JP (1999) Role of peptide backbone in T cell recognition. J Immunol 162: 4657–4662

    PubMed  CAS  Google Scholar 

  • Callan MFC, Tan L, Annels N, Ogg GS, Wilson JDK, O’Callaghan CA, Steven N, McMichael AJ, Rickinson AB (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr Virus in vivo. J Exp Med 187: 1395–1402

    Article  PubMed  CAS  Google Scholar 

  • Casanova JL, Cerottini J-C, Matthes M, Necker A, Gournier H, Barra C, Widmann C, MacDonald HR, Lemonnier F, Malissen B, Maryanski JL (1992) H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med 176: 439–447

    Article  PubMed  CAS  Google Scholar 

  • Cole GA, Hogg TL, Woodland DL (1994) The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int Immunol 6: 1767–1775

    Article  PubMed  CAS  Google Scholar 

  • Cormier JN, Salgaller ML, Prevette T, Barracchini KC, Rivoltini L, Restifo NP, Rosenberg SA, Marincola FM (1997) Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan-A. Cancer J Sci Am 3: 37–44

    PubMed  CAS  Google Scholar 

  • Crawford F, Kozono H, White J, Marrack P, Kappler J (1998) Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8: 675–682

    Article  PubMed  CAS  Google Scholar 

  • Dunbar PR, Ogg GS, Chen J, Rust N, Bruggen P van der, Cerundolo V (1998) Direct isolation, phenotyping and cloning of low frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr Biol 8: 413–416

    Article  PubMed  CAS  Google Scholar 

  • Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16: 487–494

    Article  PubMed  CAS  Google Scholar 

  • Flynn KJ, Belz GT, Altman KD, Ahmed R, Woodland DL, Doherty PC (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683–691

    Article  PubMed  CAS  Google Scholar 

  • Gallimore A, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel R (1998) Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med 187: 1383–1393

    Article  PubMed  CAS  Google Scholar 

  • Green DR, Scott DW (1994) Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6: 476–487

    Article  PubMed  CAS  Google Scholar 

  • Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardon DM, Jacobson S, Schneck JP (1998) Direct visualization of antigen-specific T cells: HTLV 1 Tax11–19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 95: 7568–7573

    Article  PubMed  CAS  Google Scholar 

  • Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien Y-H (1998) Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8: 667–673

    Article  PubMed  Google Scholar 

  • Jäger E, Ringhoffer M, Dienes HP, Arand M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A (1996) Granulocyte-macrophage-colonystimulating-factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer 67: 54–62

    Article  PubMed  Google Scholar 

  • Johnson AJ, Kariuki-Njenga M, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR (1999) Prevalent class I-restricted T-cell response to the Theiler’s virus epitope Db:VP2121–130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702–3708

    PubMed  CAS  Google Scholar 

  • Kuroda MJ, Schmitz JE, Barouch DH, Craiu A, Allen TM, Sette A, Watkins DI, Forman MA, Letvin NL (1998) Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med 187: 1373–1381

    Article  PubMed  CAS  Google Scholar 

  • Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5: 677–685

    Article  PubMed  CAS  Google Scholar 

  • Lehner PJ, Wang ECY, Moss PAH, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK (1995) Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vß17 gene segment. J Exp Med 181: 79–91

    Article  PubMed  CAS  Google Scholar 

  • Marchand M, Van Baren N, Weynants P, Brichard V, Dréno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Liénard D, Beauduin M, Dietrich P-Y, Russo V, Kerger J, Masucci G, Jäger E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, Bruggen P van der, Boon T (1999) Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 80: 219–230

    Article  PubMed  CAS  Google Scholar 

  • McMichael AJ, O’Callaghan CA (1998) A new look at T cells. J Exp Med 187: 1367–1371

    Article  PubMed  CAS  Google Scholar 

  • Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini J-C, Romero P (1999) Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J Immunol 162: 3566–3573

    PubMed  CAS  Google Scholar 

  • Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L (1996) Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93: 12433–12438

    Article  PubMed  CAS  Google Scholar 

  • Mizoguchi H, O’Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795–1798

    Article  PubMed  CAS  Google Scholar 

  • Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177–187

    Article  PubMed  CAS  Google Scholar 

  • Nestle FO, Alijagic S, Gilliet M, Yuansheng S, Grabbe S, Dummer R, Burg G, Schadendorf D (1998) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 4: 328–332

    Article  PubMed  CAS  Google Scholar 

  • Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9: 689–696

    Article  PubMed  CAS  Google Scholar 

  • Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowicz M, Ho DD, Nixon DF, McMichael AJ (1998a) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279: 2103–2106

    Article  PubMed  CAS  Google Scholar 

  • Ogg GS, Dunbar PR, Romero P, Chen J, Cerundolo V (1998b) High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 188: 1203–1208

    Article  PubMed  CAS  Google Scholar 

  • Pannetier C, Cochet M, Darche S, Casrouge A, Zöller M, Kourilsky P (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor ß chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90: 4319–4323

    Article  PubMed  CAS  Google Scholar 

  • Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y (1996) Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified HLA-A*0201binding residues. J Immunol 157: 2539–2548

    PubMed  CAS  Google Scholar 

  • Pittet MJ, Valmori D, Dunbar PR, Speiser D, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini J-C, Romero P (1999) High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of HLA-A2 individuals. J Exp Med 190: 705–716

    Article  PubMed  CAS  Google Scholar 

  • Reddish MA, MacLean GD, Koganty RR, Kan-Mitchell J, Jones V, Mitchell MS, Longenecker BM (1998) Anti-MUCI class I-restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer 76: 817–823

    Article  PubMed  CAS  Google Scholar 

  • Romero P, Pannetier C, Herman J, Jongeneel CV, Cerottini J-C, Coulie P (1995) Multiple specificities in the repertoire of a melanoma patient’s cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J Exp Med 182: 1019–1028

    Article  PubMed  CAS  Google Scholar 

  • Romero P, Gervois N, Schneider J, Escobar P, Valmori D, Pannetier C, Steinle A, Wölfel T, Liénard D, Brichard V, Van Pel A, Jotereau F, Cerottini J-C (1997) Cytolytic T lymphocyte recognition of the immunodominant HLAA*0201 restricted Melan-A/MART-1 antigenic peptide in melanoma. J Immunol 159: 2366–2374

    PubMed  CAS  Google Scholar 

  • Romero P, Cerottini J-C, Waanders G (1998a) Novel methods to monitor antigen-specific cytotoxic T cell responses in cancer immunotherapy. Mol Med Today 4: 305–312

    Article  PubMed  CAS  Google Scholar 

  • Romero P, Dunbar PR, Valmori D, Pittet MI, Ogg GS, Rimoldi D, Chen JL, Liénard D, Cerottini J-C, Cerundolo V (1998b) Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes. J Exp Med 188: 1641–1650

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4: 321–327

    Article  PubMed  CAS  Google Scholar 

  • Salcedo M, Bousso P, Ljunggren HG, Kourilsky P, Abastado JP (1998) The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur J Immunol 28: 4356–4361

    Article  PubMed  CAS  Google Scholar 

  • Salgaller ML, Marincola FM, Cormier JN, Rosenberg SA (1996) Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res 56: 4749–4757

    PubMed  CAS  Google Scholar 

  • Savage PA, Boniface JJ, Davis MM (1999) A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10: 485–492

    Article  PubMed  CAS  Google Scholar 

  • Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P, Evavold B, Sette A, Ahmed R (1998) Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 188: 71–82

    Article  PubMed  CAS  Google Scholar 

  • Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS (1997) Self antigens expressed by solid tumors do not stimulate naive or activated T cells: implications for immunotherapy. J Exp Med 186: 645–653

    Article  PubMed  CAS  Google Scholar 

  • Speiser DE, Valmori D, Rimoldi D, Pittet MJ, Liénard D, MacDonald HR, Cerottini J-C, Romero P (1998) CD28 negative cytotoxic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from melanoma patients. Eur J Immunol 29: 1900–1999

    Google Scholar 

  • Speiser DE, Pittet MJ, Valmori D, Dunbar PR, Rimoldi D, Liénard D, MacDonald HR, Cerottini J-C, Cerundolo V, Romero P (1999) In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 190: 775–782

    Article  PubMed  CAS  Google Scholar 

  • Stevenson PG, Belz GT, Altman JD, Doherty PC (1998) Virus-specific CD8+ T cell numbers are maintained during y-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci USA 95: 15565–15570

    Article  PubMed  CAS  Google Scholar 

  • Tan LC, Gudgeon N, Annels NE, Hansasuta P, O’Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MFC (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 162: 1827–1835

    PubMed  CAS  Google Scholar 

  • Valmori D, Pittet MJ, Rimoldi D, Liénard D, Dunbar R, Cerundolo V, Lejeune F, Cerottini J-C, Romero P (1999a) An antigen targeted approach to adoptive transfer therapy of cancer. Cancer Res 59: 2167–2173

    PubMed  CAS  Google Scholar 

  • Valmori D, Pittet MJ, Vonarbourg C, Rimoldi D, Liénard D, Speiser D, Dunbar R, Cerundolo V, Cerottini J-C, Romero P (1999b) Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLAA*0201-associated tyrosinase peptide 368–376. Cancer Res 59: 4050–4055

    PubMed  CAS  Google Scholar 

  • Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2 A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1. J Exp Med 188: 1841–1848

    Article  PubMed  CAS  Google Scholar 

  • Wilson JDK, Ogg GS, Allen RL, Goulder PJR, Kelleher A, Sewell AK, O’Callaghan CA, Rowland-Jones SL, Callan MFC, McMichael AJ (1998) Oligoclonal expansions of CD8+ T cells in chronic HIV infection are antigen specific. J Exp Med 188: 785–790

    Article  PubMed  CAS  Google Scholar 

  • Wilson CS, Moser JM, Altman JD, Jensen PE, Lukacher AE (1999) Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL. J Immunol 162: 3933–3941

    PubMed  CAS  Google Scholar 

  • Yanagi Y, Tishon A, Lewicki H, Cubitt BA, Oldstone MB (1992) Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J Virol 66: 2527–2531

    PubMed  CAS  Google Scholar 

  • Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD (1999) Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 162: 2227–2234

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. J. Pittet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Valmori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. E. Speiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Cerundolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Liénard
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Lejeune
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J.-C. Cerottini
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology and Allergy, Medical Faculty Charité, Humboldt University, Schumannstrasse 20/21, 10117, Berlin, Germany

    P. Walden  & W. Sterry  & 

  2. Experimental Dermatology, Schering AG, Müllerstrasse 178, 13342, Berlin, Germany

    H. Hennekes

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Romero, P. et al. (2000). Immune Monitoring in Cancer Immunotherapy. In: Walden, P., Sterry, W., Hennekes, H. (eds) Therapeutic Vaccination Strategies. Ernst Schering Research Foundation Workshop, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04183-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04183-3_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04185-7

  • Online ISBN: 978-3-662-04183-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation